Cargando…
Excess Medicaid Payments and the Stock Prices of Drug Companies
Autor principal: | Grant, William C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437950/ https://www.ncbi.nlm.nih.gov/pubmed/23127151 http://dx.doi.org/10.18553/jmcp.2012.18.8.650 |
Ejemplares similares
-
Long-Term Medicaid Excess Payments from Alleged Price Manipulation of Generic Lorazepam
por: Bian, Boyang, et al.
Publicado: (2012) -
Hospital Prices in Medicaid Managed Care
por: Marr, Jeffrey, et al.
Publicado: (2023) -
Medicaid Capitation Payments by State
por: Hsia, David C.
Publicado: (2019) -
Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019) -
Reputation, Stock Price, and You: Why the Market Rewards Some Companies and Punishes Others
por: Kossovsky, Nir
Publicado: (2012)